Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Seek immediate medical attention (call 999) for symptoms of pulmonary embolism including sudden shortness of breath, sharp chest pain, rapid heart rate, coughing blood, or feeling faint
Potential benefits: Correction of nutrient deficiencies that may hinder weight loss Improved overall health and well-being Enhanced body functions that support weight management Addressing potential nutrient deficiencies gives your body the tools it needs to function optimally, which can support your weight loss journey
The approval was based on the OASIS clinical trial programme and the SELECT cardiovascular outcomes trial, with the OASIS 4 study showing a mean weight loss of 16.6% at 64 weeks in adults with obesity or overweight, among participants who adhered to treatment
Industry Size (2025) USD 4.1 Bn Forecast (2035) USD 13 Bn CAGR (2025 to 2035) 12.2% GLP-1 Nutritional Support Market Size, Share, and Forecast Outlook 2025 to 2035 The GLP-1 nutritional support market is forecast to reach USD 13 billion by 2035, up from USD 4.1 billion in 2025, advancing at a 12.2% CAGR
US$ 29.51
US$ 20.26
US$ 22.16
US$ 21.57
US$ 24.75
US$ 21.68
US$ 24.46
